Arcutis Biotherapeutics, Inc.ARQTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank38
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Percentile
P38
Within normal range
vs 5Y Ago
-2.8x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$-2.74M+75.1%
2024$-10.99M+38.7%
2023$-17.93M-82.3%
2022$-9.83M-5782.7%
2021$173000.00-82.1%
2020$967000.00-14.9%
2019$1.14M+136.7%
2018$480000.00+155.0%
2017$-872000.00-